Literature DB >> 24879982

Hepatotoxicity induced by herbal and dietary supplements.

Victor J Navarro1, M Isabel Lucena2.   

Abstract

Herbals and dietary supplements (HDS) can cause hepatotoxicity. Regulation of HDS varies across the globe. In the United States, it is defined by a law that is now two decades old. More recent regulatory approaches in Europe still do not require testing for premarket safety. The true incidence of hepatotoxicity from HDS is unknown. The presentation is most often with a hepatocellular enzyme pattern, and the outcomes can be severe, leading to transplantation in some circumstances. The diagnosis of hepatotoxicity due to HDS is made in the same way as for drugs. However, patients often must be coaxed into revealing a history of use. No causality assessment approach is perfectly suited for hepatotoxicity from HDS, but the Roussel Uclaf Causality Assessment Method is most used. Future endeavors must focus on defining epidemiology, establishing an accepted nomenclature, and identifying culprit ingredients, predisposing host factors, and useful biomarkers for injury. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24879982     DOI: 10.1055/s-0034-1375958

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  19 in total

1.  Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum.

Authors:  Jiabo Wang; Zhijie Ma; Ming Niu; Yun Zhu; Qingsheng Liang; Yanling Zhao; Jingyuan Song; Zhaofang Bai; Yaming Zhang; Ping Zhang; Na Li; Yakun Meng; Qi Li; Lushan Qin; Guangju Teng; Junling Cao; Baosen Li; Shilin Chen; Yonggang Li; Zhengsheng Zou; Honghao Zhou; Xiaohe Xiao
Journal:  Front Med       Date:  2015-10-12       Impact factor: 4.592

Review 2.  Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.

Authors:  M Mosedale; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  2017-01-11       Impact factor: 6.875

Review 3.  Role of liver sinusoidal endothelial cells in liver diseases.

Authors:  Jordi Gracia-Sancho; Esther Caparrós; Anabel Fernández-Iglesias; Rubén Francés
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-15       Impact factor: 46.802

Review 4.  Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  World J Hepatol       Date:  2015-07-08

5.  Alternative medicine products causing acute liver injury: Pandora's box is open.

Authors:  Fanny Bergeron; Trana Hussaini; Natasha Chandok; Eric M Yoshida
Journal:  Can Liver J       Date:  2019-05-22

Review 6.  Liver injury from herbal and dietary supplements.

Authors:  Victor J Navarro; Ikhlas Khan; Einar Björnsson; Leonard B Seeff; Jose Serrano; Jay H Hoofnagle
Journal:  Hepatology       Date:  2016-11-17       Impact factor: 17.425

Review 7.  Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States.

Authors:  Paul H Hayashi
Journal:  Int J Mol Sci       Date:  2016-02-04       Impact factor: 5.923

Review 8.  Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.

Authors:  Philip Sarges; Joshua M Steinberg; James H Lewis
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.228

9.  Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury.

Authors:  Jia-Bo Wang; Yun Zhu; Zhao-Fang Bai; Fu-Sheng Wang; Xiu-Hui Li; Xiao-He Xiao
Journal:  Chin J Integr Med       Date:  2018-03-15       Impact factor: 2.626

10.  Hepatotoxic potential of asarones: in vitro evaluation of hepatotoxicity and quantitative determination in herbal products.

Authors:  Dhavalkumar N Patel; Han K Ho; Liesbet L Tan; Mui-Mui B Tan; Qian Zhang; Min-Yong Low; Cheng-Leng Chan; Hwee-Ling Koh
Journal:  Front Pharmacol       Date:  2015-02-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.